Background. Moderate alcohol consumption is cardioprotective but the mechanism of action remains unclear. Nuclear factor k-B regulates the expression of genes involved in inflammation, stress, and apoptosis. We used a swine model of diet-induced metabolic syndrome to investigate the effects of red wine and vodka on nuclear factor k-B signaling and cytokine activity in chronically ischemic myocardium. Methods. Yorkshire swine were given a high-fat diet for 4 weeks; an ameroid constrictor was then placed on the left circumflex artery. The high-fat diet was continued and the swine were divided into 3 groups for 7 weeks: hypercholesterolemic diet alone (control, n = 8), hypercholesterolemic diet with vodka (vodka, n = 8), and hypercholesterolemic diet with wine (wine, n = 8). Ischemic myocardium was analyzed by Western blot and cytokine array. Results. Administration of alcohol was associated with decreased expression of inhibitor of k-B kinase complex a, inhibitor of k-B kinase complex b, and phosphorylated inhibitor of k-B b in the ischemic myocardium compared with the control group. Alcohol administration demonstrated an increase in nuclear factor k-B in the ischemic myocardium. Both wine and vodka demonstrated a significant decrease in leptin, interleukin-1a, IL-13, IL-15, and interferon-g. Vodka demonstrated a significant decrease in phosphorylated BCL-2 and caspase-9. Conclusion. In ischemic myocardium, alcohol modulates the nuclear factor k-B pathway, which may contribute to the adaptive response of tissues to the stress of ischemia. Furthermore, both wine and vodka decreased multiple proinflammatory cytokines. This study provides a mechanism by which alcohol may be cardioprotective in ischemic myocardium. (Surgery 2017;162:680-7.) 
DIABETES AND THE ASSOCIATED METABOLIC SYNDROME are highly prevalent and growing problem in the world, affecting 422 million people with a global prevalence of 8.5% in 2014, already surpassing past predictions of reaching 7.7% by 2030.
1 Diabetes alone was responsible for 1.5 million deaths in 2012, 2 80% of which were due to conditions related to atherosclerosis including stroke, peripheral arterial disease, and most commonly, coronary artery disease. 3 Diabetes is known to increase the risk of acute coronary events by 3-to 5-fold compared with patients without elevated glucose levels. 3 The metabolic syndrome associated with type 2 diabetes and insulin resistance further increases the cardiac risks of an alreadyhigh risk population. Furthermore, patients with diabetes often have other comorbidities even beyond those of metabolic syndrome, rendering them even greater risk for coronary revascularization and poorer candidates for percutaneous coronary intervention. 4 Besides tight glucose control, there are few therapeutic preventative options for decreasing the risks of coronary artery disease in patients with diabetes. Our laboratory has demonstrated previously the beneficial effects of wine and vodka on insulin signaling in a swine model of metabolic syndrome. 5 The health benefits of daily alcohol consumption follows a J-shaped curve in which low to moderate doses (1 to 2 drinks or 15 to 30 g ethanol/d) have the greatest benefit, specifically with a reduction of risk of diabetes (30% to 40%) and cardiovascular disease compared with those who abstain. 6 The upregulation of the inflammatory response is evolutionarily intended to help heal damaged tissue; however, this process is often overactive and as a result, causes irreversible damage to cells and can result in apoptosis. Inflammatory pathways are aberrantly expressed in ischemic myocardial tissue. Nuclear factor k B (NFkB) is a transcription factor that regulates numerous genes involved in inflammation. Many of these are cytokines such as tumor necrosis factor-a (TNF-a), interferon-g (IFN-g), interleukin-1a (IL-1a), transforming growth factorb (TGF-b), IL-13, and IL-15. Cardiomyocytes that have undergone necrosis from ischemic insult have been shown to release IL-1a as a damage signal to activate fibroblasts and leukocytes. IL-1a furthermore leads to induction of cytokines and molecules involved in cellular matrix degradation. 7 This signaling seems to be a primary innate immune response that signals via the MyD88-dependent pathway.
8 IFN-g is another wellcharacterized cytokine involved in inflammation that has been shown to be associated with poor outcomes and increased mortality in patients after myocardial infarctions. 9 Beyond the innate inflammatory response, signaling of the adaptive immune response involving monocytes and B-cells is activated by myocardial ischemia. Ischemia triggers an immediate increase in levels of IL-13 and causes upregulation of TGF-b. IL-13 is known to activate the alternative macrophage pathway and activate fibroblasts via TGF-b. In IL-13 knockout mice, recovery from an ischemic event is delayed or does not occur, leading to early demise. 10 However, it is not clear what level of IL-13 and TGF-b is optimal for enhanced fibrosis and healing after an event of myocardial ischemia.
Leptin has been identified as an important component of cardiovascular health as it has been shown to be involved in angiogenesis, vascular and endothelial function, and insulin sensitivity. 11 Not surprisingly, previous studies have shown that leptin is increased in ischemic heart disease, especially in patients with metabolic syndrome/type 2 diabetes. 12 In fact, leptin levels have been shown to be 1.5-to 2-fold greater in patients with insulin resistance than those without. 13 When initial steps of inflammation continue to progress, cells begin to undergo movement towards apoptosis. Stromal cell-derived factor 1 (SDF-1) has been shown to be a regulator of stem cell migration to sites of injury, and is a chemoattractant for endogenous cardiac stem cells.
14 Akt (protein kinase B) is a unique signaling kinase active in numerous pathways, and when activated, promotes cell survival. 15 It can be phosphorylated at serine 473 by PI3K, which can be activated by various molecules including SDF-1. Another molecule in the Akt pathway is p-BCL-2, which is a proto-oncogene which, when phosphorylated, seems to be correlated with anti-apoptotic activity. 16 Therefore, mechanisms to decrease inflammation and minimizing apoptosis in the setting of ischemia are an attractive therapeutic option to improve cardiac healing.
Interestingly, alcohol has been found to attenuate inflammatory signaling. It remains unclear why red wine often is associated with greater cardiovascular benefits than other types of alcohol. Some data tout the antioxidant properties of resveratrol; however, others suggest the absorption of resveratrol is often too low to make a significant impact. 6 Here, we use a swine model of dietinduced metabolic syndrome and myocardial ischemia to investigate the effects of alcohol with resveratrol in the form of red wine and alcohol without resveratrol in the form of vodka. Given the known cardioprotective effects of alcohol, we hypothesized that alcohol modulates the NFkB pathway and downregulates inflammation and apoptosis signaling in the setting of chronic myocardial ischemia.
METHODS
Twenty-four intact male Yorkshire swine were fed a 500 g/d high-cholesterol diet consisting of 4% cholesterol, 17.2% coconut oil, 2.3% corn oil, 1.5% sodium cholate, and 75% regular chow (Sinclair Research, Columbia, MO) for 4 weeks to induce metabolic syndrome. 5 Previous data from our group has demonstrated this diet induces obesity, hyperlipidemia, hypertension, and insulin resistance that models metabolic syndrome. 17 An ameroid constrictor then was placed on the left circumflex artery to induce chronic myocardial ischemia. The high-fat diet was continued and swine were subdivided into 3 groups with supplementation of wine or vodka for 7 weeks: hypercholesterolemic diet alone (hypercholesterolemic control [control] , n = 8), hypercholesterolemic diet with vodka (hypercholesterolemic vodka [vodka] , n = 8), and hypercholesterolemic diet with wine (hypercholesterolemic wine [wine], n = 8). The wine supplementation consisted of 375 mL of red wine daily (Black Mountain pinot noir, 12.5% alcohol v/v, 0.3-0.5 mg/mL resveratrol, Haro Hills, CA). The vodka supplementation consisted of 112 mL of vodka daily (Rubinoff vodka, 40% alcohol v/v, Somerville, MA). The alcohol in each group was designed to be nearly equivalent in daily content; ie, daily wine intake is 375 mL 3 12.5% = 46.8, and daily vodka intake: 112 mL 3 40% = 44.8. Animals underwent euthanasia and ischemic myocardium was harvested for analysis. Sections from the ischemic area of myocardium were used for all analysis except where expression of NFkB was compared between the ischemic and nonischemic sections of myocardium.
OPERATIVE INTERVENTIONS
Anesthesia was induced with an intramuscular injection of telazol (4.4 mg/kg). Animals were endotracheally intubated, mechanically ventilated at 12 to 20 breaths per minute, and general anesthesia was maintained with a gas mixture of oxygen at 1.5 to 2 liters/min and isoflurane at 0.75% to 3.0% concentration.
Ameroid constrictor placement. Animals were given a single dose of antibiotic prophylaxis, intravenous enrofloxacin 5 mg/kg, and general anesthesia was induced and maintained. Animals were prepped and draped in the usual sterile fashion. The heart was exposed through a left mini-thoracotomy. The left atrial appendage was retracted and the proximal left circumflex artery was dissected at the takeoff of the left main coronary artery. The ameroid constrictor was placed around the left circumflex artery (Research Instruments SW, Escondito, CA) approximately 1 cm distal to the takeoff from the left main coronary artery. The pericardium was loosely reapproximated followed by a layered closure of the operative incision. Postoperative pain was controlled with a single dose of intramuscular Buprenorphine (0.03 mg/kg) and 72-hour Fentanyl patch (4 mg/kg). All animals received 325 mg of aspirin daily for thromboembolic prophylaxis starting 1 day preoperatively and continuing for a total of 5 days. All animals continued perioperative antibiotics: enrofloxacin 68 mg orally daily for 5 days. Experiments using these animals were done to evaluate myocardial perfusion in the chronically ischemic and normal myocardium, insulin signaling, proteomics, endothelial dysfunction, and collateral vessel formation were previously reported. 5, [18] [19] [20] [21] Cardiac harvest. Under general anesthesia, the heart was exposed through a median sternotomy and animals were euthanized by exsanguination.
Cardiac tissue from the ischemic territory in the left circumflex artery distribution as well as from nonischemic territory was collected for further analysis.
The Institutional Animal Care and Use Committee of the Rhode Island Hospital approved all experiments. Animals were cared for in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" (NIH publication no. 5377-3 1996).
PROTEIN EXPRESSION
Whole-tissue lysates were prepared from homogenized samples using bead homogenization. Protein concentration was determined using a radio-immunoprecipitation assay; Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Waltham, MA).
Western blot analysis. Whole-tissue lysates were fractionated on 4% to 20% Tris-Glycine gels (Novex Midi Protein Gels, Invitrogen, Carlsbad, CA) and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA). Primary antibodies (NFkB, phosphorylated nuclear factor
, phosphorylated Akt, heat shock protein of 90 kDa [HSP-90], phosphorylated BCL-2, SDF-1, caspase-9 and cleaved caspase-9, all from Cell Signaling, Danvers, MA) were diluted 1:1,000 and incubated on membranes overnight at 48C. GAPDH was added to all membranes to correct for loading error. After washing, a secondary antirabbit or anti-mouse antibody (Cell Signaling, Danvers, MA) was added and incubated for 1 hour at room temperature. Visualization was performed using enhanced chemiluminescence and images were captured with a digital camera system (GBox, Syngene, Cambridge, England). ImageJ software (National Institutes of Health, Bethesda, MD) was used to quantify band densitometry as arbitrary light units. Protein density data were normalized to GAPDH and reported as fold-change values ± standard error of the mean compared with control samples.
Cytokine array. Samples from each group (ie, control, wine, vodka; n = 8/group) were pooled together with 25 ug of protein in each sample for a total protein amount of 200ug. A protease and phosphatase inhibitor (Thermo Scientific, Rockford, IL) then was added. These pooled samples were then applied to an NFkB Antibody Array membrane (Abcam, Cambridge, MA) and incubated overnight at 48C. Biotin-conjugated anti-cytokines were applied to the membranes and incubated for 2 hours at room temperature. Horseradish peroxidase-conjugated streptavidin then was added to the membranes and incubated overnight at 48C. The arrays were visualized using enhanced chemiluminescence and images were captured with a digital camera system (GBox, Syngene, Cambridge, England). ImageJ software was used to quantify band densitometry as arbitrary light units.
STATISTICAL ANALYSES
Data were analyzed using GraphPad Prism 5.0 Software (GraphPad Software Inc, San Diego, CA) with a Kruskal Wallis ANOVA and a Dunn's posthoc test for between group comparisons. Results are listed as mean ± SEM.
RESULTS
Protein expression. Western blot analysis. Alcohol supplementation down regulated expression of IKKa, IKKb, and phosphorylated IkBa in the ischemic myocardium in the wine and vodka animals compared with the controls. Alcohol administration also upregulated NFkB (P = .003) expression in the ischemic myocardium, which was greater in the hypercholesterolemic vodka group than the hypercholesterolemic wine group (Fig 1) . Expression of both IKKa and NFkB was significantly different compared with the controls in the vodka group but not the wine group (IKKa: P = .004; NFkB: P = .003). In contrast, phosphorylation of IkBa was decreased significantly in the hypercholesterolemic wine group compared with the control (P = .001), while p-IkBa in the vodka group was not significantly different from the controls.
The expression of NFkB was compared between the ischemic and the nonischemic areas of myocardium in each of the 3 groups. The levels of NFkB decreased with the addition of wine and vodka in the nonischemic tissue and increased in the ischemic tissue with wine and vodka compared to the respective controls. There was a statistically significant difference between the ischemic and nonischemic groups given vodka supplementation (P < .0001, Fig 2) . There was no significant difference between the active, phosphorylated form of NFkB expression (data not shown).
There was a nonsignificant decrease in both chemokine SDF-1 as well as pro-survival protein phosphorylated-Akt in the ischemic myocardium in the vodka group; however, both SDF-1 and pAkt were nonsignificantly increased in the wine group.
Chaperone protein heat shock protein of 90kD (HSP-90) was similarly mildly increased in the wine group but not significantly compared with the control group. Phosphorylated BCL-2 and caspase-9 were both significantly decreased in the vodka group (P = .0008, P = .0052, respectively). Conversely, in the wine group, p-BCL-2 was upregulated; caspase 9 was down regulated although neither reached significance. Cleaved caspase-9 was significantly upregulated in the wine group compared with the control (P < .05), (Fig 3) .
Cytokine array. There was significantly lower expression of several cytokines in the animals supplemented with alcohol, including proinflammatory cytokines leptin (wine: P = .02, vodka: P = .02), IL-1a (wine: P = .01, vodka: P = .008), IL-13 (wine: P = .04, vodka: P = .01), IL-15 (wine: P < .001, vodka: P = .001), as shown in Table. IFN-g, another proinflammatory cytokine was also decreased in both the hypercholesterolemic wine and vodka groups compared with the control (wine: P = .01, vodka: P = .02). Expression of IL-1b was decreased significantly in the vodka group (P = .02) but did not reach significance in the wine group (P = .06). Similarly, TGF-b was significantly decreased in the hypercholesterolemic vodka group (P = .02) and the wine group (P = .05). TNF-a was not significantly different with alcohol administration in either group compared with the control group (wine: P = .11, vodka: P = .30) (Table) .
DISCUSSION
Our unique swine model of alcohol supplementation in the setting of metabolic syndrome simulates the effects of wine and vodka in a population that is particularly vulnerable to coronary artery disease. Furthermore, this patient population often is unable to undergo coronary bypass operation as a result of multiple comorbidities that render operative intervention high risk. Therefore, interventions which mitigate myocardial ischemia in this high-risk group may be particularly beneficial.
Alcohol modulates the NFkB pathway and inflammatory signaling. Alcohol seems to modulate the NFkB pathway in the setting of myocardial ischemia as demonstrated by the downregulation of many proapoptotic and proinflammatory cytokines, including leptin, IL-1, IFN-g, TGF-b, SDF-1, and caspase-9. Modulation of the NFkB pathway is demonstrated by the decreased expression of IKKa after alcohol administration, which decreased phosphorylation of IkBa. When fewer molecules of IkBa are phosphorylated, it remains bound to and inhibits the passage of NFkB into the nucleus where NFkB upregulates a variety of genes. In this study, we used NFkB p65 (RelA), which is not the active form. Therefore, the increased levels of NFkB seen under the influence of alcohol are presumed to be in the cytoplasm, bound to its inhibitor (IkBa), which is consistent with the decrease of IKKa and phosphorylated IkBa we found. Furthermore, we assessed the active form of NFkB, as well as inflammatory cytokines known to be downstream of NFkB including TNF-a and found no significant change in their activity with the addition of alcohol, further suggesting the increased levels of NFkB we found are in their inactive form (ie, bound to IkBa in the cytoplasm). The increase in NFkB seen in both the wine and vodka group compared with the control echoes previous data in a similar hamster model, in which NFkB was upregulated in animals treated with wine versus a high-fat control. 22 That study also demonstrated a decrease in inflammatory signaling. The increase in levels of NFkB with the addition of wine and vodka in the ischemic tissue compared with controls, which was not seen in the nonischemic myocardium further supports the importance of this inflammatory pathway in areas of ischemia. Many of these gene products further promote inflammation and contribute to the adaptive response of tissues, such as the myocardium in response to the stress of ischemia.
Alcohol modulates leptin signaling. Our findings that leptin levels were decreased in animals treated with wine and vodka suggests one mechanism for alcohol-induced cardioprotection. There is one prior study demonstrating an increase in leptin levels with red wine intake in humans, although the difference was only significant in the female population and the dose of alcohol was relatively low. 23 A comparison to our data is challenging given all of our animals were male and were fed with a high-fat diet to simulate metabolic syndrome, which was not examined in the study by Djurovic et al. 23 Similar to leptin, IL-15 is associated with coronary artery disease and markers such as abdominal obesity that are positively correlated with myocardial ischemia. 24 Studies have shown that after an ischemic myocardial event, IL-15 is immediately released. 25 Our data demonstrates a significant decrease in IL-15 in the animals that were supplemented with wine and vodka compared with the controls, again suggestive of a beneficial effect of alcohol on reducing inflammation after myocardial ischemia.
SDF-1 (aka CXCL12) is a chemokine involved in response to acute myocardial infarction, heart failure, and peripheral vascular disease. It is known to bind receptors CXCR7 and CXCR4, the latter of which is involved in a signaling cascade via PI3K, which modulates reactive oxygen species in mitochondria.
14 Our data suggest a decrease in SDF-1 in both the wine and vodka groups, which is unexpected. This may suggest increased signaling of stem cells to sites in need of repair after ischemia, although further analysis of this pathway to determine significance and other factors are needed.
Our data demonstrate a decrease in IL-1a levels in both the wine and vodka groups, which was statistically significant, suggesting alcohol decreases inflammation seen after myocardial ischemia seen with increased levels of IL-1a in that setting. Furthermore, it was statistically significantly lower in the vodka group compared separately with the wine group, suggesting it is not due to resveratrol. This is consistent with previous data from our group, which found administration of alcohol decreases the presence of myocardial adhesions in our swine model. 26 Similarly, a statistically significant decrease was seen in IL-1b in the vodka group, but not in the wine group, which further suggests this pathway is dampened by the effects of vodka but not wine. We demonstrated a significant decrease in IFN-g levels in both the wine and vodka groups compared with the control group, which suggests a protective effect again of alcohol on post-myocardial ischemia myocyte recovery.
Our data demonstrates a statistically significant reduction in IL-13 from baseline in both the wine and vodka groups, and a decline in TGF-b levels in the vodka group compared with the control, which may be a decline from an overactive inflammatory state to a more normal level of inflammation seen in those without metabolic syndrome.
Alcohol decreases signaling in the apoptosis pathway. Our data demonstrated nonsignificantly decreased phosphorylation of Akt and SDF-1 in the group treated with vodka compared with the control. Another molecule in the Akt pathway is p-BCL-2, whose phosphorylation was significantly decreased in the vodka group compared with the control. The decrease of these anti-apoptotic markers suggests a possible role in decreased inflammation and increased cell survival with vodka but not with wine.
Caspase-9, a pro-apoptotic marker, can be phosphorylated and inactivated by Akt, leading to a decrease in cell death. 27 Our data demonstrated a decrease in caspase-9 in both the wine and vodka groups (although only significant in the vodka group) and an increase of cleaved caspase-9 (whose function is less clear) in the wine group, suggesting decreased apoptosis with the addition of wine but not with vodka.
We have shown previously that wine and vodka increase perfusion to ischemic myocardium in our animal model. 18 This study provides a mechanism by which alcohol may have a protective effect on the heart via modification of postmyocardial ischemic inflammation and apoptosis. The decrease in inflammatory signaling with alcohol may be protective against scar formation and decreased future myocyte function. Furthermore, decreased apoptosis in ischemic myocardium may preserve cell mass which may preserve myocardial wall thickness and ventricular contractility.
Limitations. There are several limitations to this study. First, the number of animals in each group was kept to a minimum to achieve statistical significance. Also, this study does not address dose-dependent responses or treatment-length responses to exposure to wine or vodka as we used one dose and one fixed course of treatment. Furthermore, although porcine cardiac physiology is closely related to human cardiac physiology, there may be differences that limit extrapolation of this data to humans, including the finding that swine metabolize alcohol faster than humans. Finally, there may be a sex bias given that all of our animals used in this study were male and the effects of alcohol in the female population and effects on myocardial ischemia may vary.
